Skip to content
Tablet Allopathic

Winolip EZ 180 mg + 10 mg tablet

Generic: Bempedoic acid + Ezetimibe

Company: Incepta Pharmaceuticals Ltd.. Prices are as listed on BestinMeds; your pharmacy price may differ.

Strength180 mg + 10 mg
PackStrip: 350.00 taka

Reviewed by: not listed yet. Source: not listed yet.

Last updated March 17, 2025.

Compare

Same generic, same strength

Sorted by price per tablet. Ask your pharmacist before you switch brands.

Bempedoic acid + Ezetimibe 180 mg + 10 mg tablets

Prices as listed on BestinMeds.

1 brand listed
Winolip EZ (this medicine)35.00 taka per tablet

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250
Medicine guide

About this medicine

What this medicine is for, how to take it, and what to watch for.

Read the full Bempedoic acid + Ezetimibe guide

Indications

Indicated as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease who require additional lowering of LDL-C.

Dosage and administration

Administer Bempedoic Acid 180 mg & Ezetimibe 10 mg tablet orally once daily with or without food. The safety and effectiveness of this tablet have not been established in pediatric patients.

Side effects

Upper respiratory tract infection Muscle Spasms Hyperuricemia Back pain Abdominal pain or discomfort Bronchitis Pain in extremity Anemia Elevated liver enzymes

Precautions and warnings

Elevations in serum uric acid have occurred. Assess uric acid levels periodically as clinically indicated. Monitor for signs and symptoms of hyperuricemia, and initiate treatment with urate-lowering drugs as appropriate. Tendon rupture has occurred. Discontinue Bempedoic acid & Ezetimibe at the first sign of tendon rupture. Avoid combination in patients who have a history of tendon disorders or tendon rupture.

Pregnancy and lactation

Discontinue Bempedoic Acid & Ezetimibe when pregnancy is recognized unless the benefits of therapy outweigh the potential risk to the fetus. There are no available data on Bempedoic Acid & Ezetimibe use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. There is no information regarding the presence of Bempedoic Acid & Ezetimibe in human or animal milk, the effects of the drug on the breastfeed infant,or the effects of the drug on milk production. Breastfeeding is not recommended during treatment with Bempedoic Acid & Ezetimibe.

Clinical details

BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250